Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities: 2013-2025

Historic Cash from Investing Activities for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to -$19.6 million.

  • Amphastar Pharmaceuticals' Cash from Investing Activities rose 43.27% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.4 million, marking a year-over-year increase of 76.37%. This contributed to the annual value of -$124.9 million for FY2024, which is 80.75% up from last year.
  • Amphastar Pharmaceuticals' Cash from Investing Activities amounted to -$19.6 million in Q3 2025, which was down 3,039.04% from -$625,000 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Cash from Investing Activities' 5-year high stood at $15.2 million during Q1 2024, with a 5-year trough of -$508.6 million in Q2 2023.
  • Its 3-year average for Cash from Investing Activities is -$71.3 million, with a median of -$31.2 million in 2023.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Cash from Investing Activities plummeted by 44,899.56% in 2023 and then surged by 340.60% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at -$12.0 million in 2021, then spiked by 98.08% to -$229,000 in 2022, then plummeted by 44,899.56% to -$103.0 million in 2023, then spiked by 65.38% to -$35.7 million in 2024, then spiked by 43.27% to -$19.6 million in 2025.
  • Its last three reported values are -$19.6 million in Q3 2025, -$625,000 for Q2 2025, and $10.5 million during Q1 2025.